Tech Company Financing Transactions
ReGen Biologics Funding Round
ReGen Biologics, based in Hackensack, secured $1.7 million from private investors.
Transaction Overview
Company Name
Announced On
2/17/2009
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds will support the launch of the Company's Menaflex� collagen meniscus implant device in the U.S., which recently received FDA clearance.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
411 Hackensack Avenue
Hackensack, NJ 07601
USA
Hackensack, NJ 07601
USA
Phone
Website
Email Address
Overview
Develops implantable regeneration templates for knee meniscal cartilage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerald Bisbee
Chief Financial Officer
Brion Umidi
VP - Regulatory Affairs
John Dichiara
Browse more venture capital transactions:
Prev: 2/17/2009: Oasys Water venture capital transaction
Next: 2/17/2009: OpSource venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs